[HTML][HTML] Comparative analysis of heart regeneration: searching for the key to heal the heart—part II: molecular mechanisms of cardiac regeneration

JM Castillo-Casas, S Caño-Carrillo… - Journal of …, 2023 - mdpi.com
Cardiovascular diseases are the leading cause of death worldwide, among which ischemic
heart disease is the most representative. Myocardial infarction results from occlusion of a …

Emerging role of m6A modification in fibrotic diseases and its potential therapeutic effect

W Ye, X Lv, S Gao, Y Li, J Luan, S Wang - Biochemical Pharmacology, 2023 - Elsevier
Fibrosis can occur in a variety of organs such as the heart, lung, liver and kidney, and its
pathological changes are mainly manifested by an increase in fibrous connective tissue and …

Translational control by long non-coding RNAs

AC Godet, E Roussel, N Laugero, F Morfoisse… - Biochimie, 2023 - Elsevier
Long non-coding (lnc) RNAs, once considered as junk and useless, are now broadly
recognized to have major functions in the cell. LncRNAs are defined as non-coding RNAs of …

[HTML][HTML] METTL3 and METTL14-mediated N6-methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib …

X Wu, M Zeng, Y Wei, R Lu, Z Huang, L Huang… - Scientific Reports, 2024 - nature.com
As the most prevalent epitranscriptomic modification, N6-methyladenosine (m6A) shows
important roles in a variety of diseases through regulating the processing, stability and …

m6A RNA methylation: The latent string-puller in fibrosis

X He, B Tang, P Zou, Z Song, J Liu, Z Pi, Y Xiao, R Xiao - Life Sciences, 2024 - Elsevier
Fibrosis is a pathological phenomenon characterized by the aberrant accumulation of
extracellular matrix (ECM) in tissues. Fibrosis is a universally age-related disease involving …

[HTML][HTML] Non-coding RNAs: targets for Chinese herbal medicine in treating myocardial fibrosis

M Wang, M Yan, L Tan, X Zhao, G Liu… - Frontiers in …, 2024 - frontiersin.org
Cardiovascular diseases have become the leading cause of death in urban and rural areas.
Myocardial fibrosis is a common pathological manifestation at the adaptive and repair stage …

[PDF][PDF] Crosstalk of ubiquitin system and non-coding RNA in fibrosis

H Zhang, Y Zhou, C Jiang, N Jian, J Wang - International Journal of …, 2024 - ijbs.com
Chronic tissue injury triggers changes in the cell type and microenvironment at the site of
injury and eventually fibrosis develops. Current research suggests that fibrosis is a highly …

m6A 甲基化修饰非编码RNA 调控病理性心脏重塑的作用

尹功华, 徐若瑶, 张丽娟, 张一凡, 齐洁, 张钧 - 中国组织工程研究, 2024 - cjter.com
m6A 甲基化修饰非编码RNA 调控病理性心脏重塑的作用 Page 1 3252|中国组织工程研究|第28卷
|第20期|2024年7月 中国组织工程研究 Chinese Journal of Tissue Engineering Research …

METTL3 silencing suppresses cardiac fibrosis via m6A modification of SMOC2

Y He, X Pan, Z Tao, Z Chen, S Ling - 2024 - researchsquare.com
Cardiac fibrosis leads to decreased cardiac compliance, impaired systolic and diastolic
function, resulting in heart failure. M6A methylation plays a role in fibrosis development …

Myofibroblast-specific inhibition of ASPP1 alleviates myocardial fibrosis by enhancing p53 degradation

Z Pan, S Li, Y Zhang, Y Zhao, Y Zhai, C Sun, Y Guo… - 2023 - researchsquare.com
In the healing process of myocardial infarction, cardiac fibroblasts are activated and serious
cardiac fibrosis developed, which eventually leads to cardiac remodeling and heart failure …